All News
Some Psych Meds Tied to Higher Future Risk of ALS
(MedPage Today) -- Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of amyotrophic lateral sclerosis (ALS) diagnosis and a poorer pro
Read MoreTribes Question Kennedy’s Promise To Protect Them From Health Cuts
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Read MoreSTAT+: FDA reassures rare disease advocates that ‘being flexible’ is plan for gene therapy
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals.
Read MoreWhy Choose Second Opinions? Risky Cancer Searches; 18 Months to Live, 20 Years Later
(MedPage Today) -- New insights into why patients with cancer choose to go with recommendations from a second opinion rather than the initial advice.
Read MoreGlobal Stroke Deaths Still a Concern, and It's Not Just About Developing Countries
(MedPage Today) -- Though stroke mortality has decreased over the last few decades, there is still room for improvement, researchers said.
Read MoreDame June Clark obituary
Forthright president of the Royal College of Nursing who later became a government adviserWhen June Clark was elected to the governing council of the Royal College of Nursing (RCN) in 1969, becoming i
Read MorePalantir’s Collection of Disease Data at C.D.C. Stirs Privacy Concerns
U.S. and state officials say the consolidation of the public health agency’s vast trove of information could expose patients and will delay analysis of long-term trends.
Read MoreHow Trump's Pick for Surgeon General Uses Her Big Online Following to Make Money
(MedPage Today) -- President Donald Trump's pick to be the next U.S.
Read MoreWhat about fitness tips for those of us aged 90 and above? | Letters
David Bentley responds to an article on reaching peak fitness through the decades.
Read MoreGLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns
(MedPage Today) -- A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded.
Read More